Liezl Gambe

The Albanese government is considering a second raid on its flagship Cheaper Home Batteries program in just six months.

Island Pharmaceuticals (ASX:ILA) partners with USAMRIID and The Geneva Foundation to accelerate Galidesivir development for Marburg Virus Disease under the FDA Animal Rule.

Straker (ASX:STG) said that after 26 years at the helm, founder Grant Straker will step down as CEO and Managing Director, effective March 20.

The Australian economy has demonstrated resilience, recording a 0.8% expansion in the December quarter of 2025.

Treasury Wine Estates (ASX:TWE) announced that Stuart Boxer will step down from his dual role as Chief Financial and Strategy Officer, effective Sept. 30.

SSR Mining (NASDAQ:SSRM) on Wednesday announced it has entered into a binding memorandum of understanding to sell its 80% ownership stake in the Çöpler mine and related properties in Türkiye to Cengiz Holding for $1.5 billion in cash.

Caesarstone (NASDAQ:CSTE), a global pioneer in quartz and porcelain surfaces, reported a fourth-quarter net loss of $87.9 million, or $2.55 per share, as it finalized major components of its multi-year strategic transformation.

Cellectar Biosciences (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company specializing in radioconjugates, reported a significantly reduced net loss for 2025 as it transitioned its lead program, iopofosine I-131, into the final regulatory stages.

Bath & Body Works (NYSE:BBWI) reported fourth-quarter 2025 results on Wednesday that exceeded its own conservative projections, though the retailer signaled a cautious road ahead with a 2026 outlook that anticipates continued sales declines.

Dingdong (NYSE:DDL) reported a strong finish to 2025 on Wednesday, posting its eighth consecutive quarter of GAAP profitability as the grocery e-commerce pioneer prepares to exit the hyper-competitive Chinese market through a landmark sale to Meituan.